1. Home
  2. TCX vs HUMA Comparison

TCX vs HUMA Comparison

Compare TCX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$11.89

Market Cap

167.0M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

BUY

Current Price

$0.44

Market Cap

165.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TCX
HUMA
Founded
1992
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
165.7M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
TCX
HUMA
Price
$11.89
$0.44
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $1.63
AVG Volume (30 Days)
67.4K
★ 5.7M
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.37
EPS
N/A
★ N/A
Revenue
★ $362,275,000.00
$2,038,000.00
Revenue This Year
$26.83
$72.32
Revenue Next Year
$10.04
$518.79
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 6.76
N/A
52 Week Low
$8.45
$0.34
52 Week High
$25.17
$1.78

Technical Indicators

Market Signals
Indicator
TCX
HUMA
Relative Strength Index (RSI) 65.27 41.96
Support Level $8.56 $0.34
Resistance Level $15.69 $0.46
Average True Range (ATR) 0.89 0.04
MACD 0.29 0.01
Stochastic Oscillator 91.67 55.07

Price Performance

Historical Comparison
TCX
HUMA

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. The company generates key revenue from Canada and USA.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: